- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Gonadal Dysgenesis in Canada
Total 281 results
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerCanada, United States
-
CASI Pharmaceuticals, Inc.CompletedOvarian Cancer | Peritoneal Cancer | Fallopian CancerUnited States, Canada
-
Ontario Clinical Oncology Group (OCOG)PfizerCompleted
-
University Health Network, TorontoMerck Sharp & Dohme LLCActive, not recruitingAdvanced Solid Tumors | Triple Negative Breast Cancer | Epithelial Ovarian Cancer | Malignant Melanoma | Squamous Cell Cancer of Head and NeckCanada
-
SanofiRegeneron PharmaceuticalsCompletedOvarian Neoplasms | AscitesUnited States, Canada, Spain, India, Belgium, Austria, Hungary, Israel, United Kingdom
-
University of MichiganNational Cancer Institute (NCI)CompletedOvarian Cancer Risk | Risk-reducing Surgery | Fallopian Tube Fimbriae | Ovarian Cortical Inclusion CystsUnited States, Canada
-
Sunnybrook Health Sciences CentreCentre hospitalier de l'Université de Montréal (CHUM); Exactis Innovation; Princess...RecruitingOvarian Cancer | Triple Negative Breast Cancer | High Grade Serous CarcinomaCanada
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Endometrial Carcinoma | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Ovarian Sarcoma | Recurrent Ovarian Epithelial Cancer | Stage IV Endometrial Carcinoma | Ovarian Stromal Cancer | Recurrent Ovarian Germ Cell Tumor and other conditionsCanada
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian Cancer | Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage IV Borderline Ovarian...Canada
-
University of TorontoActive, not recruitingCoronary Artery Disease | Melanoma | Diabetes Mellitus, Type 2 | Cancer, Breast | Cancer, Prostate | Cancer, Ovarian | Cancer, ColorectalCanada
-
Grupo Español de Investigación en Cáncer de OvarioAstraZenecaCompletedAdvanced Ovarian CancerSpain
-
Ferring PharmaceuticalsCompletedPrimary Amenorrhea With Hypogonadotropic HypogonadismUnited States, Canada
-
Novartis PharmaceuticalsCompletedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsNetherlands, Canada, United States, Slovakia, United Kingdom
-
Canadian Cancer Trials GroupAstraZeneca; Cancer Research Institute, New York City; BioAtla, Inc.RecruitingOvarian CancerUnited States, Canada
-
AstraZenecaCompletedOvarian CancerBrazil, Panama, Colombia, Argentina, Mexico, Peru
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube Cancer | Stage IIIA Fallopian Tube Cancer | Stage IIIB Fallopian Tube Cancer | Stage IIIC Fallopian Tube Cancer and other conditionsCanada
-
Novartis PharmaceuticalsCompletedBreast Cancer | Ovarian Cancer | Colon Cancer | Endometrium CancerCanada, Netherlands, Spain, United States
-
PfizerCompletedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsUnited States, Canada
-
Opna-IO LLCTerminatedEpithelial Ovarian Cancer | Gynecologic NeoplasmsUnited States, Canada
-
Unither PharmaceuticalsTerminatedOvarian NeoplasmsCanada, United States
-
Dexa Medica GroupCompletedInsulin Resistance | Polycystic Ovary Syndrome (PCOS)Indonesia
-
NCIC Clinical Trials GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerCanada
-
AstraZenecaCompletedLymphoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Malignant Solid TumorsUnited States, Canada
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)TerminatedMaveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer (AVALON)Platinum-resistant Epithelial Ovarian CancerUnited States, Canada, Puerto Rico
-
University Health Network, TorontoCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerCanada, Spain, Australia, Italy, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedNeoplasms | Cancer of the OvaryUnited States, France, Canada, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland
-
AstraZenecaBritish Columbia Cancer AgencyCompleted
-
Aduro Biotech, Inc.Incyte CorporationTerminatedPlatinum-resistant Ovarian Cancer | Platinum-resistant Fallopian Cancer | Platinum-resistant Peritoneal CancerUnited States, Canada
-
Tesaro, Inc.RecruitingOvarian NeoplasmsSpain, United States, Canada
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)Incyte CorporationActive, not recruitingRecurrent Fallopian Tube Cancer | Recurrent Epithelial Ovarian Cancer | Recurrent Peritoneal CancerUnited States, Canada
-
BayerCompletedOvarian NeoplasmsPoland, Belgium, Spain, Hong Kong, Korea, Republic of, Canada, Italy, Singapore, Germany, United States, Netherlands, France, Japan, Finland
-
GlaxoSmithKlineActive, not recruitingBreast Neoplasms | Ovarian NeoplasmsUnited States, Austria, Denmark, Spain, Canada, France, Israel, Italy
-
The Canadian College of Naturopathic MedicineBastyr University; Lotte & John Hecht Memorial FoundationCompletedBreast Neoplasms | Colorectal Neoplasms | Pancreatic Neoplasms | Ovarian NeoplasmsUnited States, Canada
-
Translational Research in OncologyCompletedStudy of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian CancerOvarian NeoplasmsUnited States, France, Ireland, Germany, Israel, Canada, Spain
-
Astex Pharmaceuticals, Inc.CompletedOvarian CancerCanada, United States, United Kingdom
-
BayerCompletedOvarian NeoplasmsUnited States, Canada
-
Genentech, Inc.TerminatedOvarian CancerUnited States, Spain, Belgium, Canada, France, United Kingdom, Poland
-
Sunesis PharmaceuticalsCompletedEpithelial Ovarian CancerUnited States, Canada
-
Nordic Society of Gynaecological Oncology - Clinical...European Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical...CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerItaly, Canada, Israel, Norway, Belgium, Netherlands, Denmark, Portugal, Spain, United States
-
AltaRexUnknownOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States, Canada
-
Hoffmann-La RocheTerminatedTriple Negative Breast Cancer | Advanced Ovarian CancerUnited Kingdom, United States, Australia, Denmark, Canada
-
University College, LondonRecruitingOvarian CancerAustralia, United Kingdom, Canada, New Zealand
-
EMD SeronoSanofiCompletedOvarian CancerUnited States, Belgium, Canada, Australia, Spain, France, Poland
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Stage IV Fallopian Tube Cancer | Stage IV Ovarian Cancer | Stage IV Primary Peritoneal CancerUnited States, Canada
-
Hoffmann-La RocheCompletedOvarian CancerBelgium, Spain, Canada, Russian Federation, United Kingdom, Hungary, Italy, Poland, Netherlands
-
Facet BiotechBiogenTerminatedPeritoneal Neoplasms | Ovarian CancerUnited States, Canada
-
NCIC Clinical Trials GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerCanada, United Kingdom
-
AstraZenecaParexelWithdrawnOvarian CancerUnited States, Italy, Canada, Spain
-
AbbVie (prior sponsor, Abbott)CompletedOvarian CancerUnited States, Australia, Canada, Hungary, Israel, New Zealand, Poland, United Kingdom
-
Canadian Cancer Trials GroupApotex Inc.Active, not recruiting